Health.Global: Leadership in Speciality Healthcare; Operating Profitability Turning Around

137 Views30 Nov 2021 17:22
Broker
We initiate coverage on HealthCare Global Enterprises Ltd (HCG) with a BUY rating and a target price of Rs 330 (EV/EBITDA 15x for FY24E EBITDA), implying an upside potential of 32% from the current...
SUMMARY
(Sign Up to Access)
Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
  • Unlock all research summaries
  • Follow top, independent analysts
  • Receive personalised alerts and emails
  • Access Briefings, Analytics, and Events

Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.

Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.

or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 1-minute read)
Discussions
(Paid Plans Only)
chart-bar
Logo
Axis Direct
External broker reports(aggregated public sources)
Axis Direct
IndiaEquity Bottom-Up
Price Chart(Sign Up to Access)
analytics-chart
  • Health.Global: Leadership in Speciality Healthcare; Operating Profitability Turning Around
    30 Nov 2021
x